The Vascular Biology program studies the development of new blood vessels, working to uncover where stem cells go and what they do once transplanted into the body. Specific projects are looking to engineer cells and scaffolding biomaterials to make cell therapies detectable in the body after transplant using MRI, ultrasound or other imaging toolsfor conditions like diabetes, cancer and stroke. Additional studies are investigating the role of hypoxia-inducible factors (HIFs)proteins that regulate oxygen consumptionin the maintenance of cancer stem cells within breast tumors and the ability of cancer cells to evade the immune system. Continue reading →

The Vascular Biology Program at Boston Childrens Hospital takes an interdisciplinary approach to the study of physiological and pathological processes that are dependent, in some way, on adaptation of the vascular system. The pathologic conditions studied range from life threatening conditions arising from short bowel syndrome in premature infants, to infantile hemangiomas, to AMD, to urinary markers of neoplasia to metastatic cancer. Continue reading →

The European Vascular Biology Organisation (EVBO) was launched in 2006, after discussion between European vascular biologists who recognised that there is a need for a democratic society to provide a united focus and forum for vascular biologists in Europe, primarily by organising conferences but also by maintaining and enhancing an interactive network of researchers; evolving from the experience of the previous European Vascular Biology Association and building on the achievements of the FP6 European Vascular Genomics Network (EVGN). EVBO will support presenting junior EVBO members with ten awards (500/award) for the IVBM meeting in Seoul, Korea 9-12th Sept 2020. Mark apply on the Travel Awards section when submitting your abstract online. Continue reading →

Paracetamol Through studies of rats, researchers from the University of Copenhagen may have found the reason behind of a large drop in blood pressure in patients receiving intravenous pain medication. Most people know about the painkiller paracetamol, commonly used against headaches and ingested orally. However, in hospitals, paracetamol is administered intravenously Continue reading →

Abstract / Synopsis: Amid a treatment burden of regular injections, retina specialists have oved to treat-and-extend regimens, the effectiveness of which is supported by the literature. Special to Ophthalmology Times Anti-vascular endothelial growth factor (VEGF) injections are widely used in the United States for the treatment of neovascular (wet) age-related macular degeneration (AMD). Given the treatment burden of injecting these drugs on a monthly or every-other-month schedule as initially recommended, the vast majority of U.S Continue reading →